Denifanstat Update: 52-Week Data from Phase 3 Open-Label Extension in China and Planned AURORA Phase 3 Clinical Trial in US 09/30/2026 at 1:00 PM EDT Listen to webcast Supporting Materials View Presentation 1.8 MB
